{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:20:02Z","timestamp":1740108002110,"version":"3.37.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"13-16","license":[{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s00253-022-12052-4","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:02:31Z","timestamp":1657843351000},"page":"5007-5021","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Production of an anti-TNF\u03b1 antibody in murine myeloma cells by perfusion culture"],"prefix":"10.1007","volume":"106","author":[{"given":"Alexi","family":"Bueno-Soler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Palacios-Oliva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Dorvignit-Pedroso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anelis","family":"Quintana-Cantillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaima","family":"Ramirez-Roque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Santo Tomas-Pompa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquin Antonio","family":"Solazabal-Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Ruiz-Ramirez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Mateo-de Acosta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tammy","family":"Boggiano-Ayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1333-112X","authenticated-orcid":false,"given":"Thailin","family":"Lao-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,15]]},"reference":[{"key":"12052_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/bit.1059","volume":"73","author":"LM Barnes","year":"2001","unstructured":"Barnes LM, Bentley CM, Dickson AJ (2001) Characterization of the stability of recombinant protein production in the GS-NS0 expression system. Biotechnol Bioeng 73:261\u2013270","journal-title":"Biotechnol Bioeng"},{"key":"12052_CR2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/bit.10517","volume":"81","author":"LM Barnes","year":"2003","unstructured":"Barnes LM, Bentley CM, Dickson AJ (2003) Stability of protein production from recombinant mammalian cells. Biotechnol Bioeng 81:631\u2013639","journal-title":"Biotechnol Bioeng"},{"key":"12052_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/bit.10893","volume":"85","author":"LM Barnes","year":"2004","unstructured":"Barnes LM, Bentley CM, Dickson AJ (2004) Molecular definition of predictive indicators of stable protein expression in recombinant NS0 myeloma cells. Biotechnol Bioeng 85:115\u2013121","journal-title":"Biotechnol Bioeng"},{"key":"12052_CR4","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00253-011-3806-1","volume":"94","author":"T Beckmann","year":"2012","unstructured":"Beckmann T, Kr\u00e4mer O, Klausing S, Heinrich C, Th\u00fcte T, B\u00fcntemeyer H, Hoffrogge R, Noll T (2012) Effects of high passage cultivation on CHO cells: a global analysis. Appl Microbiol Biotechnol 94:659\u2013671","journal-title":"Appl Microbiol Biotechnol"},{"key":"12052_CR5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/BF02521750","volume":"9","author":"M Brown","year":"1992","unstructured":"Brown M, Renner G, Field R, Hassell T (1992) Process development for the production of recombinant antibodies using the glutamine synthetase (GS) system. Cytotechnol 9:231\u2013236","journal-title":"Cytotechnol"},{"key":"12052_CR6","first-page":"223","volume-title":"Serum and protein free media","author":"M Butler","year":"2015","unstructured":"Butler M (2015) Serum and protein free media. Springer, Animal cell culture, pp 223\u2013236"},{"key":"12052_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s13555-018-0230-9","volume":"8","author":"JM Carrascosa","year":"2018","unstructured":"Carrascosa JM, Jacobs I, Petersel D, Strohal R (2018) Biosimilar drugs for psoriasis: principles, present, and near future. Dermatol Ther 8:173\u2013194","journal-title":"Dermatol Ther"},{"key":"12052_CR8","unstructured":"Castilho LR, Medronho RA (2002) Advances in biochemical engineering biotechnology, vol 74. Managing editor: Th. Scheper. Springer-Verlag, Berln"},{"key":"12052_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1021\/bp060231v","volume":"23","author":"CY Choo","year":"2007","unstructured":"Choo CY, Tian Y, Kim WS, Blatter E, Conary J, Brady CP (2007) High-level production of a monoclonal antibody in murine myeloma cells by perfusion culture using a gravity settler. Biotechnol Prog 23:225\u2013231","journal-title":"Biotechnol Prog"},{"key":"12052_CR10","first-page":"407","volume-title":"Perfusion processes","author":"V Chotteau","year":"2015","unstructured":"Chotteau V (2015) Perfusion processes. Springer, Animal cell culture, pp 407\u2013443"},{"key":"12052_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0022-1759(92)90092-8","volume":"152","author":"MJ Coloma","year":"1992","unstructured":"Coloma MJ, Hastings A, Wims LA, Morrison SL (1992) Novel vectors for the expression of antibody molecules using variable regions generated by polymerase chain reaction. J Immunol Methods 152:89\u2013104","journal-title":"J Immunol Methods"},{"key":"12052_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.critrevonc.2016.06.002","volume":"104","author":"G Curigliano","year":"2016","unstructured":"Curigliano G, O\u2019Connor DP, Rosenberg JA, Jacobs I (2016) Biosimilars: extrapolation for oncology. Crit Rev Oncol\/hematol 104:131\u2013137","journal-title":"Crit Rev Oncol\/hematol"},{"key":"12052_CR13","doi-asserted-by":"publisher","unstructured":"Du Y, Walsh A, Ehrick R, Xu W, May K, Liu H (2012) Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies. MAbs 4(5):578\u2013585. https:\/\/doi.org\/10.4161\/mabs.21328","DOI":"10.4161\/mabs.21328"},{"key":"12052_CR14","unstructured":"EMA (2014) Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: non-clinical and clinical issues https:\/\/www.ema.europa.eu\/en\/similar-biological-medicinal-products. Accessed Jan\u00a02021"},{"key":"12052_CR15","unstructured":"FDA (2014) Guidance for industry: immunogenicity assessment for therapeutic protein products. US Food and Drug Administration, Rockville.\u00a0https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/immunogenicity-assessment-therapeutic-protein-products. Accessed Jan\u00a02021"},{"key":"12052_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.biologicals.2014.05.005","volume":"42","author":"BG Feagan","year":"2014","unstructured":"Feagan BG, Choquette D, Ghosh S, Gladman DD, Ho V, Meibohm B, Zou G, Xu Z, Shankar G, Sealey DC (2014) The challenge of indication extrapolation for infliximab biosimilars. Biol 42:177\u2013183","journal-title":"Biol"},{"key":"12052_CR17","doi-asserted-by":"publisher","unstructured":"Hong J, Lee Y, Lee C, Eo S, Kim S, Lee N, Park J, Park S, Seo D, Jeong M, Lee Y, Yeon S, Bou-Assaf G, Sosic Z, Zhang W, Jaquez O (2017) Physicochemical and biological characterization of SB2, a biosimilar of Remicade\u00ae (infliximab). MAbs 9(2):364\u2013382. https:\/\/doi.org\/10.1080\/19420862.2016.1264550","DOI":"10.1080\/19420862.2016.1264550"},{"key":"12052_CR18","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1002\/cpps.77","volume":"95","author":"M Hunter","year":"2019","unstructured":"Hunter M, Yuan P, Vavilala D, Fox M (2019) Optimization of protein expression in mammalian cells. Curr Protoc Protein Sci 95:e77","journal-title":"Curr Protoc Protein Sci"},{"key":"12052_CR19","doi-asserted-by":"crossref","unstructured":"Jefferis R (2016) Antibody posttranslational modifications.\u00a0Biosimilar mAbs\u00a0155\u2013199","DOI":"10.1002\/9781118940648.ch5"},{"key":"12052_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1021\/bp0501524","volume":"22","author":"Z Jiang","year":"2006","unstructured":"Jiang Z, Huang Y, Sharfstein ST (2006) Regulation of recombinant monoclonal antibody production in chinese hamster ovary cells: a comparative study of gene copy number, mRNA level, and protein expression. Biotechnol Prog 22:313\u2013318","journal-title":"Biotechnol Prog"},{"key":"12052_CR21","doi-asserted-by":"publisher","unstructured":"Jung SK, Lee KH, Jeon JW, Lee JW, Kwon BO, Kim YJ, Bae JS, Kim DI, Lee SY, Chang SJ (2014) Physicochemical characterization of Remsima. MAbs 6(5):1163\u20131177. https:\/\/doi.org\/10.4161\/mabs.32221","DOI":"10.4161\/mabs.32221"},{"key":"12052_CR22","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jbiosc.2009.09.044","volume":"109","author":"Y Kaneko","year":"2010","unstructured":"Kaneko Y, Sato R, Aoyagi H (2010) Evaluation of Chinese hamster ovary cell stability during repeated batch culture for large-scale antibody production. J Biosci Bioeng 109:274\u2013280","journal-title":"J Biosci Bioeng"},{"key":"12052_CR23","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/0161-5890(93)90106-L","volume":"30","author":"DM Knight","year":"1993","unstructured":"Knight DM, Trinh H, Le J, Siegel S, Shealy D, McDonough M, Scallon B, Moore MA, Vilcek J, Daddona P (1993) Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. Mol Immunol 30:1443\u20131453","journal-title":"Mol Immunol"},{"key":"12052_CR24","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/227680a0","volume":"227","author":"UK Laemmli","year":"1970","unstructured":"Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680\u2013685","journal-title":"Nature"},{"key":"12052_CR25","unstructured":"Langer ES, Rader RA (2014) Continuous bioprocessing and perfusion: wider adoption coming as bioprocessing matures. Bioprocess J 13"},{"key":"12052_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13568-020-01157-6","volume":"11","author":"T Lao-Gonzalez","year":"2021","unstructured":"Lao-Gonzalez T, Bueno-Soler A, Duran-Hernandez A, Sosa-Aguiar K, Hinojosa-Puerta LE, Hernandez-Garcia T, de la Luz-Hernandez KR, Palacios-Oliva J, Boggiano-Ayo T (2021) Screening and selection strategy for the establishment of biosimilar to trastuzumab-expressing CHO-K1 cell lines. AMB Express 11:1\u201317","journal-title":"AMB Express"},{"key":"12052_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.xphs.2019.08.009","volume":"109","author":"Y Le Basle","year":"2020","unstructured":"Le Basle Y, Chennell P, Tokhadze N, Astier A, Sautou V (2020) Physicochemical stability of monoclonal antibodies: a review. J Pharm Sci 109:169\u2013190","journal-title":"J Pharm Sci"},{"key":"12052_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ymben.2012.12.003","volume":"21","author":"V Le Fourn","year":"2014","unstructured":"Le Fourn V, Girod P-A, Buceta M, Regamey A, Mermod N (2014) CHO cell engineering to prevent polypeptide aggregation and improve therapeutic protein secretion. Metab Eng 21:91\u2013102","journal-title":"Metab Eng"},{"key":"12052_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s40259-019-00390-1","volume":"34","author":"TF Lerch","year":"2020","unstructured":"Lerch TF, Sharpe P, Mayclin SJ, Edwards TE, Polleck S, Rouse JC, Zou Q, Conlon HD (2020) Crystal structures of PF-06438179\/GP1111, an infliximab biosimilar. BioDrugs 34:77\u201387","journal-title":"BioDrugs"},{"key":"12052_CR30","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s10529-007-9449-8","volume":"29","author":"H Liu","year":"2007","unstructured":"Liu H, Gaza-Bulseco G, Chumsae C, Newby-Kew A (2007) Characterization of lower molecular weight artifact bands of recombinant monoclonal IgG1 antibodies on non-reducing SDS-PAGE. Biotechnol Lett 29:1611\u20131622","journal-title":"Biotechnol Lett"},{"key":"12052_CR31","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.molimm.2006.02.020","volume":"44","author":"A Lopez-Requena","year":"2007","unstructured":"Lopez-Requena A, De Acosta CM, Moreno E, Gonzalez M, Puchades Y, Talavera A, Vispo NS, Vazquez AM, Perez R (2007) Towards a molecular dissection of an idiotype-anti-idiotype system. Mol Immunol 44:423\u2013433","journal-title":"Mol Immunol"},{"key":"12052_CR32","first-page":"1","volume":"4","author":"RN Maini","year":"2002","unstructured":"Maini RN, Feldmann M (2002) How does infliximab work in rheumatoid arthritis? Arthritis Research Ther 4:1\u20137","journal-title":"Arthritis Research Ther"},{"key":"12052_CR33","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/btpr.67","volume":"24","author":"CF Mandenius","year":"2008","unstructured":"Mandenius CF, Brundin A (2008) Bioprocess optimization using design-of-experiments methodology. Biotechnol Prog 24:1191\u20131203","journal-title":"Biotechnol Prog"},{"key":"12052_CR34","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0003-2697(81)90783-1","volume":"117","author":"JH Morrissey","year":"1981","unstructured":"Morrissey JH (1981) Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal Biochem 117:307\u2013310","journal-title":"Anal Biochem"},{"key":"12052_CR35","doi-asserted-by":"crossref","unstructured":"Myers MM, Keating C, Bannon J, Neblock DS, Wojciechowski PW (2010) Addressing changes associated with technology transfer: a case study. Curr Trends mAb Dev Mfg Springer 75\u201385","DOI":"10.1007\/978-0-387-76643-0_6"},{"key":"12052_CR36","first-page":"373","volume-title":"Building a cell culture process with stable foundations: searching for certainty in an uncertain world","author":"PMR O\u2019Callaghan","year":"2015","unstructured":"O\u2019Callaghan PMR, Andrew J (2015) Building a cell culture process with stable foundations: searching for certainty in an uncertain world. Springer, Animal Cell Culture, pp 373\u2013406"},{"key":"12052_CR37","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/btpr.2655","volume":"34","author":"NA Patel","year":"2018","unstructured":"Patel NA, Anderson CR, Terkildsen SE, Davis RC, Pack LD, Bhargava S, Clarke HR (2018) Antibody expression stability in CHO clonally derived cell lines and their subclones: role of methylation in phenotypic and epigenetic heterogeneity. Biotechnol Prog 34:635\u2013649","journal-title":"Biotechnol Prog"},{"key":"12052_CR38","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1002\/bit.23269","volume":"108","author":"CA Sellick","year":"2011","unstructured":"Sellick CA, Croxford AS, Maqsood AR, Stephens G, Westerhoff HV, Goodacre R, Dickson AJ (2011a) Metabolite profiling of recombinant CHO cells: designing tailored feeding regimes that enhance recombinant antibody production. Biotechnol Bioeng 108:3025\u20133031","journal-title":"Biotechnol Bioeng"},{"key":"12052_CR39","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/nprot.2011.366","volume":"6","author":"CA Sellick","year":"2011","unstructured":"Sellick CA, Hansen R, Stephens GM, Goodacre R, Dickson AJ (2011b) Metabolite extraction from suspension-cultured mammalian cells for global metabolite profiling. Nat Protoc 6:1241\u20131249","journal-title":"Nat Protoc"},{"key":"12052_CR40","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1021\/ac950914h","volume":"68","author":"A Shevchenko","year":"1996","unstructured":"Shevchenko A, Wilm M, Vorm O, Mann M (1996) Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Anal Chem 68:850\u2013858","journal-title":"Anal Chem"},{"key":"12052_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1478-6354-13-S1-S2","volume":"13","author":"JS Smolen","year":"2011","unstructured":"Smolen JS, Emery P (2011) Infliximab: 12 years of experience. Arthritis Res Ther 13:1\u201318","journal-title":"Arthritis Res Ther"},{"key":"12052_CR42","doi-asserted-by":"publisher","first-page":"1700227","DOI":"10.1002\/biot.201700227","volume":"13","author":"G Stolfa","year":"2018","unstructured":"Stolfa G, Smonskey MT, Boniface R, Hachmann AB, Gulde P, Joshi AD, Pierce AP, Jacobia SJ, Campbell A (2018) CHO-omics review: the impact of current and emerging technologies on chinese hamster ovary based bioproduction. Biotechnol J 13:1700227","journal-title":"Biotechnol J"},{"key":"12052_CR43","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0003-2697(79)90732-2","volume":"98","author":"RC Switzer III","year":"1979","unstructured":"Switzer RC III, Merril CR, Shifrin S (1979) A highly sensitive silver stain for detecting proteins and peptides in polyacrylamide gels. Anal Biochem 98:231\u2013237","journal-title":"Anal Biochem"},{"key":"12052_CR44","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ab.2009.05.043","volume":"392","author":"J Vlasak","year":"2009","unstructured":"Vlasak J, Bussat MC, Wang S, Wagner-Rousset E, Schaefer M, Klinguer-Hamour C, Kirchmeier M, Corva\u00efa N, Ionescu R, Beck A (2009) Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody. Anal Biochem 392:145\u2013154","journal-title":"Anal Biochem"},{"key":"12052_CR45","unstructured":"WHO (2009) Guidelines on evaluation of similar biotherapeutic products (SBPs) https:\/\/www.who.int\/biologicals\/biotherapeutics\/similar_biotherapeutic_products\/en\/ (accessed January, 2021.)."},{"key":"12052_CR46","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jpba.2013.04.030","volume":"83","author":"ZC Zhu","year":"2013","unstructured":"Zhu ZC, Chen Y, Ackerman MS, Wang B, Wu W, Li B, Obenauer-Kutner L, Zhao R, Tao L, Ihnat PM (2013) Investigation of monoclonal antibody fragmentation artifacts in non-reducing SDS-PAGE. J Pharm Biom Anal 83:89\u201395","journal-title":"J Pharm Biom Anal"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-022-12052-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00253-022-12052-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-022-12052-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T02:14:42Z","timestamp":1658974482000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00253-022-12052-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,15]]},"references-count":46,"journal-issue":{"issue":"13-16","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["12052"],"URL":"https:\/\/doi.org\/10.1007\/s00253-022-12052-4","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"type":"print","value":"0175-7598"},{"type":"electronic","value":"1432-0614"}],"subject":[],"published":{"date-parts":[[2022,7,15]]},"assertion":[{"value":"14 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Endnotes"}}]}}